| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Quantitative atlas of membrane transporter proteins: development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria.
|
Pharm Res
|
2008
|
1.93
|
|
2
|
Transcriptomic and quantitative proteomic analysis of transporters and drug metabolizing enzymes in freshly isolated human brain microvessels.
|
Mol Pharm
|
2011
|
1.25
|
|
3
|
Quantitative proteomics of transporter expression in brain capillary endothelial cells isolated from P-glycoprotein (P-gp), breast cancer resistance protein (Bcrp), and P-gp/Bcrp knockout mice.
|
Drug Metab Dispos
|
2012
|
1.13
|
|
4
|
Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
|
Mol Pharm
|
2012
|
1.09
|
|
5
|
Role of inducible nitric oxide synthase in skeletal adaptation to acute increases in mechanical loading.
|
J Bone Miner Res
|
2002
|
1.00
|
|
6
|
Quantitative membrane protein expression at the blood-brain barrier of adult and younger cynomolgus monkeys.
|
J Pharm Sci
|
2011
|
1.00
|
|
7
|
Resource allocation in public hospitals: is it effective?
|
Health Policy
|
2006
|
0.93
|
|
8
|
Amyloid-β peptide(1-40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier.
|
J Neurochem
|
2011
|
0.93
|
|
9
|
Quantitative atlas of blood-brain barrier transporters, receptors, and tight junction proteins in rats and common marmoset.
|
J Pharm Sci
|
2013
|
0.92
|
|
10
|
Quantitative targeted absolute proteomics-based ADME research as a new path to drug discovery and development: methodology, advantages, strategy, and prospects.
|
J Pharm Sci
|
2011
|
0.90
|
|
11
|
Quantitative targeted absolute proteomics-based large-scale quantification of proline-hydroxylated α-fibrinogen in plasma for pancreatic cancer diagnosis.
|
J Proteome Res
|
2013
|
0.84
|
|
12
|
Quantitative expression of human drug transporter proteins in lung tissues: analysis of regional, gender, and interindividual differences by liquid chromatography-tandem mass spectrometry.
|
J Pharm Sci
|
2013
|
0.83
|
|
13
|
Molecular-weight-dependent, anionic-substrate-preferential transport of β-lactam antibiotics via multidrug resistance-associated protein 4.
|
Drug Metab Pharmacokinet
|
2011
|
0.81
|
|
14
|
Healthcare rationing: a guide to policy directions in Sri Lanka.
|
Health Policy
|
2005
|
0.80
|
|
15
|
Quantitative targeted proteomics for understanding the blood-brain barrier: towards pharmacoproteomics.
|
Expert Rev Proteomics
|
2014
|
0.80
|
|
16
|
Identification of transporters associated with Etoposide sensitivity of stomach cancer cell lines and methotrexate sensitivity of breast cancer cell lines by quantitative targeted absolute proteomics.
|
Mol Pharmacol
|
2012
|
0.79
|
|
17
|
Attenuation of prostaglandin E2 elimination across the mouse blood-brain barrier in lipopolysaccharide-induced inflammation and additive inhibitory effect of cefmetazole.
|
Fluids Barriers CNS
|
2011
|
0.78
|
|
18
|
Validation of uPA/SCID mouse with humanized liver as a human liver model: protein quantification of transporters, cytochromes P450, and UDP-glucuronosyltransferases by LC-MS/MS.
|
Drug Metab Dispos
|
2014
|
0.77
|
|
19
|
[Multi-disciplinary research approaches on the brain barrier transport system, a dynamic interface].
|
Brain Nerve
|
2013
|
0.75
|
|
20
|
Genomic Knockout of Endogenous Canine P-Glycoprotein in Wild-Type, Human P-Glycoprotein and Human BCRP Transfected MDCKII Cell Lines by Zinc Finger Nucleases.
|
Pharm Res
|
2014
|
0.75
|